Literature DB >> 2951601

Binding of 3H-spiperone and 3H-(-)-sulpiride to dopamine D2 receptors in rat striatal membranes: methodological considerations and demonstration of the identical nature of the binding sites for the two ligands.

S Urwyler, D Coward.   

Abstract

In order to test the hypothesis emerging from the literature that 3H-sulpiride and 3H-spiperone might label different subclasses of dopamine D2 receptors in the brain, the binding properties of the two ligands were compared under optimized conditions. 3H-sulpiride was found to show a very fast rate of dissociation from the receptor. Furthermore, with this ligand, an apparently "specific" binding to glass fiber filters was observed. A centrifugation assay was therefore used for the characterization of 3H-sulpiride binding. The binding of 3H-spiperone was measured in a way which prevented its attachment to sites other than D2 receptors. Under these conditions, the two ligands were found to label identical dopaminergic recognition sites (D2 receptors) according to the following criteria: 3H-sulpiride and 3H-spiperone both labelled only one single site with a comparable density. Identical changes in the receptor number for both ligands were found in the tissue from animals with nigrostriatal 6-hydroxydopamine lesions. The potencies of various dopamine agonists and antagonists in displacing 3H-sulpiride or 3H-spiperone from their binding sites showed a highly significant one to one correlation. Finally, the binding of both ligands could be inactivated by pretreatment of the membranes with N-ethylmaleimide, with or without Na+-ions being present. This inactivation followed exactly the same kinetics for both radioligands. Thus, no indication supporting the hypothesis that 3H-sulpiride and 3H-spiperone might label different subsets of dopamine D2 receptors in the rat brain could be found.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2951601     DOI: 10.1007/bf00177711

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  35 in total

Review 1.  Multiple receptors for dopamine.

Authors:  J W Kebabian; D B Calne
Journal:  Nature       Date:  1979-01-11       Impact factor: 49.962

2.  The role of hormone receptors and GTP-regulatory proteins in membrane transduction.

Authors:  M Rodbell
Journal:  Nature       Date:  1980-03-06       Impact factor: 49.962

3.  Interactions of agonists with D-2 dopamine receptors: evidence for a single receptor population existing in multiple agonist affinity-states in rat striatal membranes.

Authors:  M W Hamblin; S E Leff; I Creese
Journal:  Biochem Pharmacol       Date:  1984-03-15       Impact factor: 5.858

4.  Conversion of dopamine D1 receptors from high to low affinity for dopamine.

Authors:  P Seeman; C Ulpian; D Grigoriadis; I Pri-Bar; O Buchman
Journal:  Biochem Pharmacol       Date:  1985-01-01       Impact factor: 5.858

Review 5.  The classification of dopamine receptors: relationship to radioligand binding.

Authors:  I Creese; D R Sibley; M W Hamblin; S E Leff
Journal:  Annu Rev Neurosci       Date:  1983       Impact factor: 12.449

6.  Evidence for essential thiol groups and disulfide bonds in agonist and antagonist binding to the dopamine receptor.

Authors:  E T Suen; E Stefanini; Y C Clement-Cormier
Journal:  Biochem Biophys Res Commun       Date:  1980-09-30       Impact factor: 3.575

7.  Selective labelling of dopamine (D2) receptors in rat striatum by [3H]domperidone but not by [3H]spiperone.

Authors:  S Lazareno; S R Nahorski
Journal:  Eur J Pharmacol       Date:  1982-07-09       Impact factor: 4.432

8.  Effect of guanine nucleotides on dopaminergic agonist and antagonist affinity for [3H]sulpiride binding sites in rat striatal membrane preparations.

Authors:  S B Freedman; J A Poat; G N Woodruff
Journal:  J Neurochem       Date:  1981-09       Impact factor: 5.372

9.  Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.

Authors:  S Urwyler; R Markstein
Journal:  J Neurochem       Date:  1986-04       Impact factor: 5.372

10.  Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions.

Authors:  S J List; P Seeman
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

View more
  7 in total

1.  Pharmacological characterization of RP 62203, a novel 5-hydroxytryptamine 5-HT2 receptor antagonist.

Authors:  A Doble; D Girdlestone; O Piot; D Allam; J Betschart; A Boireau; A Dupuy; C Guérémy; J Ménager; J L Zundel
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

2.  SDZ PSD 958, a novel D1 receptor antagonist with potential limbic selectivity.

Authors:  R Markstein; P Gull; C Rüdeberg; S Urwyler; A L Jaton; K McAllister; A K Dixon; D Hoyer
Journal:  J Neural Transm (Vienna)       Date:  1996       Impact factor: 3.575

3.  Mono- and divalent cations modulate the affinities of brain D1 and D2 receptors for dopamine by a mechanism independent of receptor coupling to guanyl nucleotide binding proteins.

Authors:  S Urwyler
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-04       Impact factor: 3.000

4.  3- and 4-O-sulfoconjugated and methylated dopamine: highly reduced binding affinity to dopamine D2 receptors in rat striatal membranes.

Authors:  E Werle; T Lenz; G Strobel; H Weicker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-07       Impact factor: 3.000

5.  Effects of chronic antidepressant treatment on dopamine-related [3H]SCH 23390 and [3H]spiperone binding in the rat striatum.

Authors:  P R Paetsch; A J Greenshaw
Journal:  Cell Mol Neurobiol       Date:  1992-12       Impact factor: 5.046

6.  Down-regulation of beta-adrenergic and dopaminergic receptors induced by 2-phenylethylamine.

Authors:  P R Paetsch; A J Greenshaw
Journal:  Cell Mol Neurobiol       Date:  1993-06       Impact factor: 5.046

7.  [O-methyl-11C]N-(4-(4-(3-Chloro-2-methoxyphenyl)-piperazin-1-yl)butyl)-1H-indole-2-carboxamide ([11C]BAK4-51) Is an Efflux Transporter Substrate and Ineffective for PET Imaging of Brain D₃ Receptors in Rodents and Monkey.

Authors:  Jeih-San Liow; Cheryl L Morse; Shuiyu Lu; Michael Frankland; George L Tye; Sami S Zoghbi; Robert L Gladding; Anver B Shaik; Robert B Innis; Amy H Newman; Victor W Pike
Journal:  Molecules       Date:  2018-10-23       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.